Case of MYB-Rearranged Prostatic Adenoid Cystic Carcinoma.

Sha Liu, Yuhan Liu, Ziyu Zhang, Shuiping Yin, Xinyi Wu, Ying Dai, Yingying Du

Abstract readCase Reports

In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sha LiuDepartment of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.

Yuhan LiuFirst Clinical Medical College, Anhui Medical University, Hefei 230032, China.

Ziyu ZhangDepartment of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.

Shuiping YinDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.

Xinyi WuFirst Clinical Medical College, Anhui Medical University, Hefei 230032, China.

Ying DaiDepartment of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.

Yingying DuDepartment of Oncology, The Fifth Affiliated Hospital of Anhui Medical University, Fuyang 236000, China.

Funding

Health Commission of Anhui Province AHWJ2025A10063

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Adenoid CysticGene RearrangementProstatic NeoplasmsProto-Oncogene Proteins c-mybHumansMaleMiddle AgedMYB protein, humanProto-Oncogene Proteins c-mybbasal cell carcinomamolecular classificationMYB gene rearrangementplatinum-based chemotherapyprostatic adenoid cystic carcinoma

Identifiers

PMID42782874

DOI10.3390/curroncol33090527

PMCPMC13605576

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.